دورية أكاديمية
أعرض في EDS

Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?

التفاصيل البيبلوغرافية
العنوان: Interleukin-18 in Brazilian Rheumatoid Arthritis Patients: Can Leflunomide Reduce It?
المؤلفون: Gualberto Cardoso PR; Laboratory of Immunomodulation and New Therapeutic Approaches (LINAT), Research Group on Immunomodulation and New Therapeutic Approaches Suely Galdino (Nupit SG), Federal University of Pernambuco, Recife, Brazil., Diniz Lopes Marques C; Clinics Hospital, Federal University of Pernambuco, Recife, Brazil., de Melo Vilar K; Laboratory of Immunomodulation and New Therapeutic Approaches (LINAT), Research Group on Immunomodulation and New Therapeutic Approaches Suely Galdino (Nupit SG), Federal University of Pernambuco, Recife, Brazil., Dantas AT; Clinics Hospital, Federal University of Pernambuco, Recife, Brazil., Branco Pinto Duarte AL; Clinics Hospital, Federal University of Pernambuco, Recife, Brazil., Pitta IDR; Laboratory of Immunomodulation and New Therapeutic Approaches (LINAT), Research Group on Immunomodulation and New Therapeutic Approaches Suely Galdino (Nupit SG), Federal University of Pernambuco, Recife, Brazil., Galdino da Rocha Pitta M; Laboratory of Immunomodulation and New Therapeutic Approaches (LINAT), Research Group on Immunomodulation and New Therapeutic Approaches Suely Galdino (Nupit SG), Federal University of Pernambuco, Recife, Brazil., Barreto de Melo Rêgo MJ; Laboratory of Immunomodulation and New Therapeutic Approaches (LINAT), Research Group on Immunomodulation and New Therapeutic Approaches Suely Galdino (Nupit SG), Federal University of Pernambuco, Recife, Brazil.
المصدر: Autoimmune diseases [Autoimmune Dis] 2021 May 10; Vol. 2021, pp. 6672987. Date of Electronic Publication: 2021 May 10 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Hindawi Country of Publication: United States NLM ID: 101546750 Publication Model: eCollection Cited Medium: Print ISSN: 2090-0422 (Print) Linking ISSN: 20900430 NLM ISO Abbreviation: Autoimmune Dis Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2011- : New York : Hindawi
Original Publication: London : SAGE-Hindawi Access to Research
مستخلص: Objectives: Rheumatoid arthritis affects about 1% of the world's population. This is a chronic autoimmune disease. It is predominant in females with progressive joint damage. Immune cells are involved, especially Th1/Th17 lymphocytes and their inflammatory cytokines. These proteins have different functions in the immune system, such as IL-16 is a chemotactic factor; IL-18 can activate NF κ B transcription producing inflammatory proteins; IL-31 can activate the JAK/STAT pathway which leads to the production of inflammatory factors in chronic diseases; IL-33 promotes IL-16 secretion which causes lymphocyte recruitment, and IL-32 and IL-34 appear to increase TNF secretion by macrophages activation in AR. The aim of this study was to evaluate serum levels of IL-16, IL-18, IL-31, IL-32, IL-33, and IL-34 and compare them with the severity and treatment of RA patients if there are any correlations.
Methods: A total of 140 RA patients and 40 healthy donors were recruited from the Department of Rheumatology at Hospital das Clínicas from the Federal University of Pernambuco. 60 AR patients were naïve for any treatment. Serum cytokine levels were determined using an ELISA kit.
Results: Serum IL-16 ( p  = 0.0491), IL-18 ( p  < 0.0001), IL-31 ( p  = 0.0004), and IL-32 ( p  = 0.0040) levels were significantly increased in RA patients compared with healthy donors. It was observed that patients using leflunomide had the lowest IL-18 levels, close to controls levels ( p  = 0.0064).
Conclusion: IL-16, IL-18, IL-31, and IL-32 are increased in the serum of RA patients. IL-18 is at lower levels in those AR who are taking leflunomide as treatment.
Competing Interests: The authors declare that there are no conflicts of interest regarding the publication of this paper.
(Copyright © 2021 Pablo Ramon Gualberto Cardoso et al.)
References: Innate Immun. 2012 Oct;18(5):675-84. (PMID: 22278935)
J Immunol. 2010 Sep 15;185(6):3472-80. (PMID: 20693421)
Eur J Histochem. 2017 May 24;61(2):2791. (PMID: 28735521)
Tissue Antigens. 2015 Oct;86(4):276-8. (PMID: 26302971)
Scand J Rheumatol Suppl. 1999;112:23-9. (PMID: 10668524)
Lab Invest. 2001 Oct;81(10):1371-83. (PMID: 11598150)
Cytokine. 2006 Jan 21;33(2):106-10. (PMID: 16487722)
Immunol Invest. 2016 Jul;45(5):383-95. (PMID: 27219123)
Exp Mol Med. 2008 Apr 30;40(2):237-45. (PMID: 18446062)
J Immunol. 1996 Jan 1;156(1):310-5. (PMID: 8598478)
Clin Exp Rheumatol. 2015 Jul-Aug;33(4):551-8. (PMID: 26203933)
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3298-303. (PMID: 16492735)
Arthritis Rheum. 2010 Sep;62(9):2569-81. (PMID: 20872595)
J Clin Invest. 1999 Nov;104(10):1393-401. (PMID: 10562301)
Curr Rheumatol Rep. 2002 Jun;4(3):201-7. (PMID: 12010604)
Open Rheumatol J. 2018 Sep 18;12:160-170. (PMID: 30288187)
J Allergy Clin Immunol. 2013 Aug;132(2):446-54.e5. (PMID: 23694808)
Eur J Immunol. 2014 Jun;44(6):1575-81. (PMID: 24737461)
J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):645-50. (PMID: 9802374)
J Rheumatol. 2012 Jul;39(7):1320-5. (PMID: 22589261)
Lancet. 2016 Oct 22;388(10055):2023-2038. (PMID: 27156434)
Immunotherapy. 2017 Mar;9(4):331-337. (PMID: 28303765)
Arthritis Res Ther. 2018 Jun 8;20(1):122. (PMID: 29884223)
Cytokine. 2016 Feb;78:87-93. (PMID: 26700586)
Oncotarget. 2017 Mar 7;8(10):16430-16444. (PMID: 28147314)
Inflammation. 2013 Feb;36(1):103-9. (PMID: 22945280)
J Rheumatol. 2012 Nov;39(11):2220; author reply 2221. (PMID: 23118293)
J Interferon Cytokine Res. 2011 Oct;31(10):745-51. (PMID: 21864160)
Drug Discov Today. 2014 Aug;19(8):1212-6. (PMID: 24906044)
Inflamm Res. 2014 Apr;63(4):309-15. (PMID: 24419251)
N Engl J Med. 2001 Mar 22;344(12):907-16. (PMID: 11259725)
Ann N Y Acad Sci. 2009 Sep;1173:301-9. (PMID: 19758166)
Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):347-56. (PMID: 18926762)
J Dermatolog Treat. 2017 Nov;28(7):591-599. (PMID: 28145790)
Blood. 2000 May 1;95(9):2869-74. (PMID: 10779433)
Arthritis Rheum. 1995 Jan;38(1):44-8. (PMID: 7818570)
Oncotarget. 2017 Jul 25;8(30):49253-49263. (PMID: 28512269)
Free Radic Res. 2014 Apr;48(4):461-5. (PMID: 24460011)
Immunity. 2005 Nov;23(5):479-90. (PMID: 16286016)
J Immunol. 2015 Apr 15;194(8):3890-900. (PMID: 25732728)
Cytokine Growth Factor Rev. 2015 Oct;26(5):545-58. (PMID: 26198770)
Reumatologia. 2019;57(2):72-77. (PMID: 31130744)
تواريخ الأحداث: Date Created: 20210531 Latest Revision: 20240402
رمز التحديث: 20240402
مُعرف محوري في PubMed: PMC8131162
DOI: 10.1155/2021/6672987
PMID: 34055402
قاعدة البيانات: MEDLINE
الوصف
تدمد:2090-0422
DOI:10.1155/2021/6672987